Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroyuki Tawada is active.

Publication


Featured researches published by Hiroyuki Tawada.


Bioorganic & Medicinal Chemistry | 2003

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

Tomoyasu Ishikawa; Nobuyuki Matsunaga; Hiroyuki Tawada; Noritaka Kuroda; Yutaka Nakayama; Yukio Ishibashi; Mitsumi Tomimoto; Yukihiro Ikeda; Yoshihiko Tagawa; Yuji Iizawa; Kenji Okonogi; Shohei Hashiguchi; Akio Miyake


Chemical & Pharmaceutical Bulletin | 1982

Studies on Antidiabetic Agents. I. Synthesis of 5-[4-(2-Methyl-2-phenylpropoxy)-benzyl] thiazolidine-2, 4-dione (AL-321) and Related Compounds

Takashi Sohda; Katsutoshi Mizuno; Hiroyuki Tawada; Yasuo Sugiyama; Takeshi Fujita; Yutaka Kawamatsu


Archive | 1998

Sulfonamide derivatives, their production and use

Hiroyuki Tawada; Fumio Toyonaka-shi Ito; Norihiko Moriya; Zen-ichi Terashita


Chemical & Pharmaceutical Bulletin | 1990

Studies on Antidiabetic Agents. IX. : A New Aldose Reductase Inhibitor, AD-5467, and Related 1, 4-Benzoxazine and 1, 4-Benzothiazine Derivatives : Synthesis and Biological Activity

Hiroyuki Tawada; Yasuo Sugiyama; Hitoshi Ikeda; Yujiro Yamamoto; Kanji Meguro


Atherosclerosis | 1995

TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters

Yasuo Sugiyama; Eiichiro Ishikawa; Hiroyuki Odaka; Nanami Miki; Hiroyuki Tawada; Hitoshi Ikeda


The Journal of Antibiotics | 2000

Studies on Anti-MRSA Parenteral Cephalosporins I. Synthesis and Antibacterial Activity of 7β-[2-(5-Amino-l52, 4-thiadiazol-3-yl)-2(Z)-hydroxyiminoacetamido]-3-(substituted imidazo[1, 2-6]-pyridazinium-1-yl)methyl-3-cephem-4-carboxylates and Related Compounds

Tomoyasu Ishikawa; Kjeiji Kamiyama; Nobuyuki Matsunaga; Hiroyuki Tawada; Yuji Iizawa; Kenji Okonogi; Akio Miyake


Archive | 1997

Oxazolone derivatives and their use as anti-Helicobacter pylori agent

Tsuneo Kanamaru; Masafumi Nakao; Hiroyuki Tawada; Keiji Kamiyama


Chemical & Pharmaceutical Bulletin | 1982

Studies on Antidiabetic Agents. III. 5-Arylthiazolidine-2, 4-diones as Potent Aldose Reductase Inhibitors

Takashi Sohda; Katsutoshi Mizuno; Eiko Imamiya; Hiroyuki Tawada; Kanji Meguro; Yutaka Kawamatsu; Yujiro Yamamoto


Chemical & Pharmaceutical Bulletin | 1991

Synthesis and Biological Activities of New 1, 4-Benzothiazine Derivatives

Masahiro Kajino; Katsutoshi Mizuno; Hiroyuki Tawada; Yumiko Shibouta; Kohei Nishikawa; Kanji Meguro


Archive | 1999

SULFONAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF

Hiroshi Banno; Fumio Itoh; Hiroyuki Tawada; Zen-ichi Terashita

Collaboration


Dive into the Hiroyuki Tawada's collaboration.

Top Co-Authors

Avatar

Kanji Meguro

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yutaka Kuwada

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hitoshi Ikeda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hideaki Natsugari

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Makoto Yamashita

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mari Adachi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Misayo Sera

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yasuo Sugiyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Isao Aoki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshiaki Sato

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge